Heinz Burgmann
Overview
Explore the profile of Heinz Burgmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jorda A, Ensle D, Eser H, Glotzl F, Riedl B, Szell M, et al.
Clin Microbiol Infect
. 2024 Nov;
31(3):451-458.
PMID: 39505067
Objectives: The real-world effectiveness of the oral antivirals nirmatrelvir-ritonavir and molnupiravir against the SARS-CoV-2 Omicron variant remains uncertain. We aimed to estimate their effectiveness in non-hospitalized adults with COVID-19. Methods:...
2.
Vossen M, Kartnig F, Mrak D, Simader E, Stiasny K, Kain R, et al.
Wien Klin Wochenschr
. 2024 Oct;
136(21-22):598-607.
PMID: 39446203
Impaired immune response to COVID-19 (coronavirus disease 2019) vaccination has been reported in patients with inborn errors of immunity (IEI). Repetitive vaccinations are recommended for this vulnerable group. Due to...
3.
Schubert L, Chen R, Weiss-Tessbach M, Kriz R, Obermuller M, Jackwerth M, et al.
Infection
. 2024 Oct;
53(1):467-474.
PMID: 39404980
Purpose: As they are effective and well tolerated, aminopenicillins are still the cornerstone for the treatment of enterococcal infections. Current treatment guidelines for infective endocarditis (IE) recommend combination treatments, which...
4.
Hotz J, Staudacher M, Schefberger K, Spettel K, Schmid K, Kriz R, et al.
BMC Infect Dis
. 2024 Sep;
24(1):899.
PMID: 39223565
Background: The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and...
5.
Kriz R, Spettel K, Pichler A, Schefberger K, Sanz-Codina M, Lotsch F, et al.
J Antibiot (Tokyo)
. 2024 Jul;
77(11):757-767.
PMID: 39080477
Cefiderocol, a novel siderophore cephalosporin, demonstrates promising in vitro activity against multidrug-resistant Gram-negative bacteria, including carbapenemase-producing strains. Nonetheless, only a few reports are available regarding the acquisition of resistance in...
6.
Obermueller M, Traby L, Weiss-Tessbach M, Kriz R, Spettel K, Schneider L, et al.
Int J Antimicrob Agents
. 2024 Mar;
63(5):107135.
PMID: 38458357
Introduction: Peritonitis remains the major infectious complication in the setting of peritoneal dialysis (PD). Despite known only moderate pathogenicity, the most frequently detected pathogens in PD-related peritonitis are surprisingly coagulase-negative...
7.
Camp I, Fuszl A, Selitsch B, Krockel I, Kovac K, Wahrmann M, et al.
Clin Microbiol Infect
. 2024 Mar;
30(6):816-821.
PMID: 38432432
Objectives: The diagnosis of invasive Candida infection remains challenging because of tests with slow turnaround times or mediocre performance. T2magnetic resonance imaging is a new diagnostic tool. We investigated the...
8.
Staudacher M, Hotz J, Kriz R, Schefberger K, Schneider L, Spettel K, et al.
Emerg Microbes Infect
. 2023 Dec;
13(1):2292077.
PMID: 38055244
Invasive infections are associated with a high burden of disease, case fatality rate and healthcare costs. Oxazolidinones such as linezolid and tedizolid are considered potential treatment choices for conditions involving...
9.
Tobudic S, Bahrs C, Schneider L, Paulussen E, Bartonickova L, Hagel S, et al.
Infection
. 2023 Jul;
51(6):1749-1758.
PMID: 37462895
Purpose: This study aimed to compare treatment outcomes for bloodstream infections (BSI) caused by a piperacillin/tazobactam (PIP/TAZ)-susceptible E. coli among three patient groups: BSI caused by ampicillin/sulbactam (AMP/SLB)-resistant isolates treated...
10.
Harrison N, Burgmann H, Rabitsch W, Honsig C, Robak O
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992240
Patients after hematopoietic stem cell transplantation (HSCT) are vulnerable to infections due to severe immunosuppression. Live-attenuated vaccines are contraindicated for two years after HSCT. The aim of this study was...